In a preclinical study show that their small molecule drug, SRI-42127, can potently attenuate the triggers of neuroinflammation. These experiments in glial cell cultures and mice now open the door to testing SRI-42127 in models of acute and chronic neurological injury.
from Latest Science News -- ScienceDaily https://ift.tt/3kBakyX
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment